Hints and tips:
...ConvaTec’s most important but most volatile OEM sales line is for diabetes insulin pumps, where US manufacturer Medtronic has a near monopoly. Its house brokers are UBS and Goldman Sachs....
...The latest issue involves one of its biggest customers, understood to be Medtronic, choosing to reduce inventory....
...ConvaTec did not identify the company but analysts named it as medical devices company Medtronic and people familiar with the situation did not dispute this....
...For Medtronic, it would mean diversification away from its traditional focus (spine)....
...New York-listed Medtronic will buy the gynaecology division for $350m....
...Smith & Nephew drifted 2 per cent to £11.39 even after Medtronic, its US peer, won a tax case that will free up about $3bn of cash trapped in Puerto Rico....
.... ($33bn, 13 per cent)Medtronic plc ($29bn, 18 per cent)Abbott Laboratories ($22bn, 19 per cent)General Electric ($104bn, 15 per cent)Eaton Corp. ($15bn, 8 per cent)Cisco Systems Inc. ($66bn, 19 per cent...
...Medtronic and Workday report quarterly earnings....
The activist fund is likely to take issue with the conglomerate structure
...Samsung Electronics last month announced an alliance with Medtronic to deliver real-time health data from medical devices — allowing doctors and patients to monitor symptoms and manage treatments remotely...
...Merger and acquisition activity has also buoyed valuations, with $10bn-plus deals announced between Allergan and Actavis, Covidien and Medtronic, Hospira and Pfizer as well as CareFusion and Becton Dickinson...
...Medtronic, a medical devices company, has started offering to treat patients with cardiac conditions at a single fixed price through its network of so-called “catheterisation laboratories”, where doctors...
...Medical device maker Medtronic reports fourth-quarter results and there are first-quarter earnings from discount retailer Dollar General....
...Medtronic chose a different response to the White House crackdown. Rather than scrap its planned $43bn acquisition of Ireland-based Covidien, the US medical devices maker restructured its financing....
...Medtronic of the US last month completed its near-$50bn takeover of Ireland-based Covidien and Zimmer last year bought Biomet for $13.4bn....
...Bankers say that, after huge deals such as Acatvis’s $66bn acquisition of Allergan and the $42.9bn takeover of Medtronic by Covidien in 2014, activity this year is more concentrated around mid-sized deals...
...The above is a clause from the Medtronic/Covidien merger agreement of course – although it allows Medtronic to walk away from the deal if US tax law prevents the company ‘inverting’ to Covidien’s Irish domicile...
...Medtronic, which has a market value of $60.5bn, will pay Covidien shareholders $93.22 a share....
...Medtronic had a market capitalisation of $60.5bn....
...Medtronic, a medical device maker, has pressed ahead with its $42.9bn acquisition of rival Covidien in a deal that will give it a tax-efficient Irish address....
...a spate of dealmaking in the sector, including the unsuccessful $40bn offer from Pfizer of the US for AstraZeneca and the proposed $50bn merger of Ireland’s Coiven with American medical device company Medtronic...
...News that Medtronic, the medical devices group, will press on with its purchase of Ireland’s Covinden boosted Shire by 4.3 per cent to £54.55....
...Medtronic, which has struck a $42.9bn deal to buy Ireland-based Covidien, has $13bn of cash outside the US....
...According to data compiled for the Financial Times, just three of the companies that have agreed to do inversions – AbbVie, Medtronic and Applied Materials – hold at least $21bn offshore....
...Collapse of the Salix acquisition will raise fresh questions over the fate of other pending inversions, such as the $42.9bn acquisition of Dublin-based Covidien by Medtronic, the US medical devices company...
International Edition